It can lower estrogen in some women, especially with weight loss
Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous GLP-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine
The results showed that the protein expressions of these two parameters were significantly progressively increased from groups 1 and 2 to group 5, suggesting an intrinsic response to ischemic stimulation that was further augmented by DPP4 D and Sita therapy (Fig
For women interested in hormone-related effects, our guide on semaglutide and estrogen levels examines the research on how GLP-1 therapy interacts with female hormones
O., Kuhlthau, K., Parker, R
A 2025 review by McGuire and colleagues in Current Reviews in Musculoskeletal Medicine found no adequately powered randomised controlled trial